Study: Living in disadvantaged neighborhood shortens breast cancer survival

by Lori SolomonBreast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 inJAMA Network

Updated on: January 29,2024

Study: Living in disadvantaged neighborhood shortens breast cancer survival

by Lori SolomonBreast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 inJAMA Network

Updated on:January 29,2024

Multiple myeloma survival down with high ADAR1 RNA expression

(HealthDay)—Amplification of the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene is associated with reduced survival in multiple myeloma (MM), according to a study p

Updated on: March 30,2024

Multiple myeloma survival down with high ADAR1 RNA expression

(HealthDay)—Amplification of the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene is associated with reduced survival in multiple myeloma (MM), according to a study p

Updated on:March 30,2024

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Updated on: May 20,2024

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Updated on:May 20,2024

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

by Osaka UniversityTargeted alpha therapy using an astatine-labeled PSMA ligand ([At-211]PSMA5). Credit: Tadashi Watabe (Osaka University)As the saying goes, when all you have is a hammer, everyt

Updated on: February 23,2024

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

by Osaka UniversityTargeted alpha therapy using an astatine-labeled PSMA ligand ([At-211]PSMA5). Credit: Tadashi Watabe (Osaka University)As the saying goes, when all you have is a hammer, everyt

Updated on:February 23,2024

Bolstering fat cells offers potential new leukemia treatment

by McMaster UniversityFat cells (white circles) in healthy human bone marrow, left, compared to bone marrow in a patient with leukemia, right. Credit: McMaster UniversityKilling cancer cells indi

Updated on: April 14,2024

Bolstering fat cells offers potential new leukemia treatment

by McMaster UniversityFat cells (white circles) in healthy human bone marrow, left, compared to bone marrow in a patient with leukemia, right. Credit: McMaster UniversityKilling cancer cells indi

Updated on:April 14,2024

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on: January 02,2024

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on:January 02,2024

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in

Updated on: January 30,2024

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in

Updated on:January 30,2024

New breast cancer screening guidelines call for earlier and more-intensive screening for high-risk women

byElsevierCredit: Unsplash/CC0 Public DomainNew American College of Radiology breast cancer screening guidelines now call for all women—particularly Black and Ashkenazi Jewish women—to have risk

Updated on: January 12,2024

New breast cancer screening guidelines call for earlier and more-intensive screening for high-risk women

byElsevierCredit: Unsplash/CC0 Public DomainNew American College of Radiology breast cancer screening guidelines now call for all women—particularly Black and Ashkenazi Jewish women—to have risk

Updated on:January 12,2024

In breast-cancer prevention, race matters

by The Ohio State UniversityCredit: CC0 Public DomainAfrican-American women at high risk of breast cancer are less likely than white women to pursue potentially life-saving preventive care, and r

Updated on: April 22,2024

In breast-cancer prevention, race matters

by The Ohio State UniversityCredit: CC0 Public DomainAfrican-American women at high risk of breast cancer are less likely than white women to pursue potentially life-saving preventive care, and r

Updated on:April 22,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on: January 02,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on:January 02,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

No radiotherapy an option for older breast cancer patients, study shows

by University of EdinburghCredit: Unsplash/CC0 Public DomainRadiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.The addition of radiothe

Updated on: February 18,2024

No radiotherapy an option for older breast cancer patients, study shows

by University of EdinburghCredit: Unsplash/CC0 Public DomainRadiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.The addition of radiothe

Updated on:February 18,2024